2
September 2024
Avacta Group
plc
("Avacta", the "Group" or the "Company")
Director/PDMR
Shareholdings
and
Total Voting
Rights
Avacta Group plc (AIM: AVCT),
a life sciences company developing innovative, targeted oncology drugs and powerful
diagnostics, announces that a total of
3,600,000 options over ordinary shares of 10p each ("Ordinary
Shares") were granted to Christina Coughlin, MD, PhD, Chief
Executive Officer (the "Options") on 30 August 2024.
The Options were granted under the
Company's Long Term Incentive Plan, Avacta Group plc Executive
Share Option Scheme and are time-based, vesting in three equal
tranches over three years to 1 May 2027. The exercise price of the
Options is 72p, being the closing mid-market share price of the
Company's ordinary shares on the 29 August 2024.
Also on 30 August 2024, Tony
Gardiner, CFO, exercised 500,000 options and sold the resulting
ordinary shares of 10p each at an average price of 71.07 pence per
share. The exercise price of the options was 10p per ordinary
share. Tony Gardiner continues to retain 2,328,324 options over
Ordinary Shares.
As previously announced Tony
Gardiner stepped down from the Board on 26 June 2024 but will be
remaining as CFO until 31st October 2024 whilst the
search for a new permanent CFO is undertaken.
Following the allotment of the
500,000 ordinary shares issued as a result of the exercise of
options by Tony Gardiner, the Company's enlarged issued share
capital is 362,159,730 ordinary shares of 10p each. This figure may
be used by shareholders in the Company as the denominator for the
calculations by which they will determine if they are required to
notify their interest in, or a change to their interest in, the
share capital of the Company under the Financial Conduct
Authority's Disclosure Guidance and Transparency Rules.
-Ends-
For
further information from Avacta Group plc, please
contact:
|
Avacta Group plc
Christina Coughlin, CEO
Michael Vinegrad, Group
Communications Director
|
Tel: +44
(0) 1904 21 7070
www.avacta.com
|
|
Peel Hunt (Nomad and Broker)
James Steel / Chris
Golden / Patrick Birkholm
|
www.peelhunt.com
|
|
ICR
Consilium
Mary-Jane Elliott / Jessica Hodgson
/ Sukaina Virji
|
avacta@consilium-comms.com
|
About Avacta Group plc - www.avacta.com
Avacta Group is a UK-based
life sciences company focused on improving healthcare outcomes
through targeted cancer treatments and diagnostics.
Avacta Therapeutics: a clinical
stage oncology biotech division harnessing proprietary therapeutic
platforms to develop novel, highly targeted cancer
drugs.
Avacta Diagnostics focuses on
supporting healthcare professionals and broadening access to
diagnostics.
Avacta has two proprietary
platforms, pre|CISION™ and Affimer®.
The pre|CISION™ platform is a highly
specific substrate for fibroblast activation protein (FAP) which is
upregulated in most solid tumours compared with healthy tissues.
The pre|CISION™ platform harnesses this tumour specific protease to
activate pre|CISION™ peptide drug conjugates and pre|CISION™
antibody/Affimer® drug conjugates in the tumour
microenvironment, reducing systemic exposure and toxicity, allowing
dosing to be optimised to deliver the best outcomes for
patients.
The lead pre|CISION™ programme
AVA6000, a peptide drug conjugate form of doxorubicin, is in Phase
1 studies. It has shown an improvement in safety and tolerability
in clinical trials to date compared with standard doxorubicin and
preliminary signs of clinical activity in multiple
patients.
To register for news alerts by email
go to www.avacta.com/investor-news-email-alerts
Notification and public
disclosure of transactions by persons discharging managerial
responsibilities and persons closely associated with
them
|
1.
|
Details of the person discharging managerial responsibilities
/ person closely associated
|
|
a)
|
Name
|
Christina Coughlin
|
|
2.
|
Reason for the Notification
|
|
a)
|
Position/status
|
Chief Executive Officer
|
|
b)
|
Initial
notification/Amendment
|
|
|
3.
|
Details of the issuer, emission allowance market participant,
auction platform, auctioneer or auction monitor
|
|
a)
|
Name
|
Avacta Group Plc
|
|
b)
|
LEI
|
2138009U3EG31OPMGH36
|
|
4.
|
Details of the transaction(s): section to be repeated for (i)
each type of instrument; (ii) each type of transaction; (iii) each
date; and (iv) each place where transactions have been
conducted
|
|
a)
|
Description of the Financial
instrument, type of instrument
|
|
Options over Ordinary
Shares
|
|
|
Identification code
|
GB00BYYW9G87
|
|
b)
|
Nature of the transaction
|
|
Grant of Options over Ordinary
Shares
|
|
|
c)
|
Price(s) and volume(s)
|
LTIP
|
Exercise Price(s)
|
Volume(s)
|
|
72.00 pence
|
3,600,000
|
|
|
d)
|
Aggregated information:
· Aggregated volume
· Price
|
As above
|
|
e)
|
Date of the transaction
|
30 August 2024
|
|
f)
|
Place of the transaction
|
Outside a trading venue
|
|
1.
|
Details of the person discharging managerial responsibilities
/ person closely associated
|
|
a)
|
Name
|
Tony Gardiner
|
|
2.
|
Reason for the Notification
|
|
a)
|
Position/status
|
Chief Financial Officer
|
|
b)
|
Initial
notification/Amendment
|
|
|
3.
|
Details of the issuer, emission allowance market participant,
auction platform, auctioneer or auction monitor
|
|
a)
|
Name
|
Avacta Group Plc
|
|
b)
|
LEI
|
2138009U3EG31OPMGH36
|
|
4.
|
Details of the transaction(s): section to be repeated for (i)
each type of instrument; (ii) each type of transaction; (iii) each
date; and (iv) each place where transactions have been
conducted
|
|
a)
|
Description of the Financial
instrument, type of instrument
|
|
|
Identification code
|
GB00BYYW9G87
|
|
b)
|
Nature of the transaction
|
|
Exercise of Options over Ordinary
Shares
|
|
|
c)
|
Price(s) and volume(s)
|
LTIP
|
Exercise Price(s)
|
Volume(s)
|
|
10.0 pence
|
500,000
|
|
|
d)
|
Aggregated information:
· Aggregated volume
· Price
|
As above
|
|
e)
|
Date of the transaction
|
30 August 2024
|
|
f)
|
Place of the transaction
|
Outside a trading venue
|
|
1.
|
Details of the person discharging managerial responsibilities
/ person closely associated
|
|
a)
|
Name
|
Tony Gardiner
|
|
2.
|
Reason for the Notification
|
|
a)
|
Position/status
|
Chief Financial Officer
|
|
b)
|
Initial
notification/Amendment
|
|
|
3.
|
Details of the issuer, emission allowance market participant,
auction platform, auctioneer or auction monitor
|
|
a)
|
Name
|
Avacta Group Plc
|
|
b)
|
LEI
|
2138009U3EG31OPMGH36
|
|
4.
|
Details of the transaction(s): section to be repeated for (i)
each type of instrument; (ii) each type of transaction; (iii) each
date; and (iv) each place where transactions have been
conducted
|
|
a)
|
Description of the Financial
instrument, type of instrument
|
|
|
Identification code
|
GB00BYYW9G87
|
|
b)
|
Nature of the transaction
|
|
|
c)
|
Price(s) and volume(s)
|
|
Price(s)
|
Volume(s)
|
|
71.07 pence
|
500,000
|
|
|
d)
|
Aggregated information:
· Aggregated volume
· Price
|
As above
|
|
e)
|
Date of the transaction
|
30 August 2024
|
|
f)
|
Place of the transaction
|
London Stock Exchange, AIM
Market
|